Clinical Report: Follow the Guidelines for Stroke in the Eye
Overview
Retinal artery occlusions, including CRAO and BRAO, should be treated as strokes requiring urgent evaluation by stroke specialists, such as neurologists or ophthalmologists, at certified stroke centers. Timely intervention is critical for preserving vision and preventing further neurological damage.
Background
Retinal artery occlusions represent a significant ocular emergency that can lead to permanent vision loss. Understanding the urgency of these conditions is crucial for optometrists and healthcare providers, as timely intervention can significantly impact patient outcomes. Current guidelines emphasize the need for immediate stroke workup and treatment at certified stroke centers. The incidence of CRAO is approximately 1.9 per 100,000 in the United States.
Data Highlights
No specific numerical data provided in the source material.
Key Findings
- CRAO and BRAO are classified as ocular strokes requiring urgent evaluation.
- Time is critical; delays in treatment can lead to irreversible vision loss.
- Current guidelines advocate for immediate transfer to certified stroke centers for management.
- Thrombolysis within 4.5 hours may improve visual outcomes in acute cases.
- The interventional evidence base is evolving, with ongoing trials assessing treatment efficacy.
Clinical Implications
Healthcare professionals should be vigilant in recognizing symptoms of retinal artery occlusions and act swiftly to facilitate patient transfer to stroke centers. Implementing protocols for rapid assessment, such as using remote OCT, can enhance patient outcomes and preserve vision.
Conclusion
Recognizing retinal artery occlusions as strokes is essential for timely intervention. Adhering to established guidelines can significantly improve patient care and visual prognosis. Healthcare professionals are urged to act promptly upon recognizing symptoms.
References
- Oregon Health & Science University, Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®, 2025 -- Guidelines for management of retinal artery occlusions
- Retinal Physician, Remote OCT Protocol to Speed Diagnosis and Treatment of CRAO, 2025 -- Improving treatment timelines for CRAO
- Retinal Physician, CONTROVERSIES IN CARE: Workup of Acute Retinal Artery Occlusion, 2022 -- Discussion on management settings for RAO
- Optometric Management — Eye Care STAT
- Ophthalmology Management — Know your tools, help your patients
- Ophthalmology Management, Know your tools, help your patients, 2017 -- Resources for eye care professionals
- Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern® - Oregon Health & Science University
- Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4·5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial - ScienceDirect
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


